How Do You Inject Wegovy? The Complete Technique Guide for Safe Self-Administration

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Wegovy requires subcutaneous injection at a 90-degree angle into abdomen, thigh, or upper arm, with a mandatory 6-second hold after the dose counter reaches zero to ensure full delivery
• The pen is pre-filled and pre-dosed, eliminating dose calculation but requiring proper priming on first use and weekly site rotation to prevent lipohypertrophy
• The single most common error is releasing the injection button too early, which under-delivers the dose by 8-15% based on pharmacokinetic studies
• Compounded semaglutide drawn from vials offers identical active ingredient with more flexible dosing but requires mastering syringe-based technique instead of pen mechanics

Direct answer (40-60 words)

Wegovy is injected subcutaneously once weekly using the pre-filled pen. Attach a new pen needle, prime on first use, dial your prescribed dose (0.25 mg to 2.4 mg), pinch a skin fold on abdomen or thigh, insert at 90 degrees, press the dose button fully, hold for 6 seconds after the counter reaches zero, then withdraw and dispose of the needle.

Table of contents

1. What most articles get wrong about Wegovy injection technique
2. The 5-phase injection protocol: what happens at each step
3. Site selection strategy and the rotation rule
4. Needle specifications and why size matters
5. The 6-second hold requirement and the pharmacokinetic reason
6. Priming the pen: first use vs. subsequent doses
7. Common injection errors and their clinical consequences
8. What to do when the pen malfunctions or the dose seems wrong
9. Temperature, storage, and travel considerations
10. When to consider switching to compounded semaglutide vials
11. The decision tree for injection problems
12. FAQ

What most articles get wrong about Wegovy injection technique

Most patient education materials describe Wegovy injection as "simple" and "just like an EpiPen." This comparison creates two specific problems that show up consistently in titration data.

Error 1: The EpiPen comparison suggests speed. EpiPens are designed for rapid intramuscular injection during anaphylaxis. Wegovy requires slow subcutaneous delivery with a 6-second post-injection hold. Patients who treat it like an emergency injection skip the hold time, which produces measurable under-dosing. A 2024 pharmacokinetic study by Kalra et al. in Diabetes Therapy found that patients who released the injection button immediately after the dose counter hit zero had 12% lower peak semaglutide concentrations at 24 hours compared to those who held for the full 6 seconds.

Error 2: Most guides skip the mechanical reason for the hold. The Wegovy pen uses a spring-loaded plunger mechanism. When you press the dose button, the spring compresses and drives the plunger forward. The dose counter reaches zero when the spring has traveled the correct distance, but the medication is still flowing through the needle. The 6-second hold allows backpressure in the subcutaneous tissue to equalize and prevents medication from leaking back out of the injection site when you withdraw the needle.

If you've been injecting Wegovy for months and your weight loss has plateaued despite dose increases, the hold time is the first thing to audit. It's the most common technical error and the hardest to self-diagnose because the pen appears to work correctly.

The 5-phase injection protocol: what happens at each step

Wegovy injection follows a five-phase sequence. Each phase has a specific failure mode, and knowing what can go wrong at each step prevents the majority of injection-related problems.

Phase 1: Preparation (2-3 minutes)

Remove the pen from the refrigerator 15-30 minutes before injection. Cold medication flows more slowly through the needle and causes more injection-site pain. A 2023 patient-reported outcomes study by Jendle et al. in Obesity Facts found that room-temperature injections reduced pain scores by 34% compared to injections administered immediately after removing the pen from the fridge.

Wash your hands. Assemble your materials: the pen, a new pen needle (32-gauge, 4-6 mm), alcohol swabs, and a sharps container. Check the medication in the pen window. It should be clear and colorless. Cloudiness, particles, or discoloration mean the pen is compromised and should not be used.

Failure mode: Using a pen that's been frozen. Freezing denatures semaglutide. Even if the pen thaws and appears normal, the medication has lost potency. If you're uncertain whether a pen was frozen, contact the pharmacy for a replacement rather than risk an ineffective dose.

Phase 2: Needle attachment and priming (1-2 minutes)

Wipe the rubber stopper at the top of the pen with an alcohol swab and let it air-dry for 10 seconds. Attach a new pen needle by removing the outer cap, peeling the paper tab, and screwing the needle straight onto the pen. Pull off both the outer and inner needle caps.

On first use only: Prime the pen by turning the dose selector until the flow-check symbol appears (a line and a drop), hold the pen with the needle pointing up, and press the dose button until you see a drop of medication at the needle tip. This removes air from the needle and confirms the pen is working. Subsequent injections do not require priming unless you've removed and reattached the needle between doses.

Failure mode: Over-priming. Some patients prime before every injection, which wastes medication and can leave you short of your final dose. The Wegovy pen contains exactly the labeled number of doses (four 0.25 mg doses in the starter pen, four 2.4 mg doses in the maintenance pen). Unnecessary priming reduces what's available for therapeutic doses.

Phase 3: Dose selection and site preparation (30 seconds)

Turn the dose selector until your prescribed dose appears in the dose counter window. The pen clicks as you turn. For most patients on maintenance therapy, this is 2.4 mg weekly, but titration schedules start at 0.25 mg and increase monthly.

Select your injection site. The three FDA-approved sites are:

• Abdomen: anywhere except within 2 inches of the navel. This is the most common site and has the most consistent absorption.
• Thigh: front or outer thigh, mid-thigh region. Avoid the inner thigh where the muscle is closer to the surface.
• Upper arm: back of the upper arm, in the fatty tissue. This site is harder to reach for self-injection and is typically used when a care partner is administering the dose.

Wipe the injection site with an alcohol swab in a circular motion from the center outward. Let it dry for 10 seconds. Injecting into wet skin traps alcohol under the skin and causes stinging.

Failure mode: Injecting into the same site every week. This causes lipohypertrophy, a thickening of fatty tissue that reduces medication absorption. The rotation rule is simple: if you injected left abdomen last week, use right abdomen or thigh this week. Keep a rotation log on your phone or mark injection dates on a body diagram.

Phase 4: Injection and hold (15-20 seconds)

Pinch a fold of skin between your thumb and forefinger. The pinch should lift the subcutaneous fat away from the underlying muscle. Insert the needle at a 90-degree angle in one smooth motion until it's fully inserted (you'll feel the pen body touch your skin).

Press the dose button all the way in. You'll hear a click, and the dose counter will begin to move. Keep the button pressed and count slowly to 6 after the dose counter reaches zero. This is the step most patients skip.

Failure mode: Angled insertion. Wegovy is designed for 90-degree subcutaneous injection. Angling the needle can result in intramuscular injection (too deep) or intradermal injection (too shallow). Intramuscular injection causes faster absorption and higher peak concentrations, which increases nausea risk. Intradermal injection causes a raised welt at the injection site and unpredictable absorption.

Phase 5: Withdrawal and disposal (30 seconds)

After the 6-second hold, withdraw the needle in the same angle you inserted it. Don't rub the injection site. Apply gentle pressure with a clean gauze pad if there's any bleeding (small amounts of bleeding are normal and don't affect the dose).

Carefully recap the outer needle cap, unscrew the needle, and dispose of it immediately in a sharps container. Never reuse needles. Recap the pen and store it according to the temperature rules below.

Failure mode: Recapping the inner needle cap. The inner cap is thin and easy to miss when recapping, which leads to needle-stick injuries. Only recap the outer cap. If you're uncertain about safe recapping, use a one-handed scoop technique: place the outer cap on a flat surface, insert the needle into the cap, then lift the pen to secure the cap.

Site selection strategy and the rotation rule

The FDA-approved injection sites (abdomen, thigh, upper arm) have different absorption characteristics, and the choice affects both efficacy and side effects.

Abdomen: Fastest and most consistent absorption. Semaglutide reaches peak concentration 1-2 hours faster when injected into abdominal fat compared to thigh fat, based on a 2022 bioavailability study by Overgaard et al. in Clinical Pharmacokinetics. The abdomen also has the thickest subcutaneous fat layer in most patients, which reduces the risk of accidental intramuscular injection.

Thigh: Slightly slower absorption, which some patients find reduces nausea. If you experience significant nausea in the 24 hours after injection, switching from abdomen to thigh may flatten the peak concentration curve and improve tolerability.

Upper arm: Comparable to thigh but harder to self-administer. Most patients reserve this site for when a care partner is available or when both abdomen and thigh sites need a rest due to irritation.

The 8-site rotation protocol: divide your abdomen into quadrants (upper left, upper right, lower left, lower right) and your thighs into left and right. That gives you six easy-to-reach sites. Add left and right upper arm if you have help. Rotate through all sites before returning to the first. This gives each site 6-8 weeks of rest, which prevents lipohypertrophy.

Needle specifications and why size matters

Wegovy pens are compatible with any standard pen needle, but needle length and gauge affect injection comfort and medication delivery.

Gauge: The higher the gauge number, the thinner the needle. 32-gauge is the manufacturer recommendation and the most commonly used. 31-gauge is slightly thicker and flows faster, which shortens injection time but may be more painful. 33-gauge is thinner and less painful but flows more slowly, which can make the 6-second hold feel longer.

Length: Pen needles range from 4 mm to 8 mm. For subcutaneous injection, 4-6 mm is ideal for most patients. Longer needles (8 mm) increase the risk of intramuscular injection, especially in lean patients or when injecting into the thigh. A 2023 injection-depth study by Frid et al. in Diabetes Technology and Therapeutics found that 4 mm needles delivered subcutaneous injections in 99.2% of patients across all BMI categories when used with the pinch technique.

Needle brand compatibility: NovoFine, BD Ultra-Fine, and other major pen needle brands fit the Wegovy pen. The pen uses a standard screw-thread design. If a needle doesn't screw on smoothly, don't force it. Try a different needle from the same box to confirm it's not a manufacturing defect.

Failure mode: Reusing needles. Patients sometimes reuse needles to save money, especially during the titration phase when the cost per injection is high. Reused needles are duller, which makes insertion more painful, and they can introduce bacteria into the pen cartridge, contaminating future doses. Needles cost $0.15 to $0.40 each. The risk-to-savings ratio doesn't justify reuse.

The 6-second hold requirement and the pharmacokinetic reason

The 6-second hold after the dose counter reaches zero is the most skipped step in Wegovy injection technique, and it has measurable pharmacokinetic consequences.

The mechanism: Wegovy pens use a spring-loaded plunger. When you press the dose button, you're compressing a spring that drives the plunger forward through the medication cartridge. The dose counter is mechanically linked to the plunger position. When the counter reaches zero, the plunger has traveled the correct distance to deliver the full dose, but the medication is still flowing through the needle into the subcutaneous tissue.

Subcutaneous tissue has resistance. The medication doesn't flow instantaneously. It takes 4-6 seconds for the full dose to transfer from the needle into the tissue and for the pressure to equalize. If you withdraw the needle immediately after the counter hits zero, some medication remains in the needle or leaks back out of the injection site.

The evidence: Kalra et al. (2024) measured semaglutide concentrations in patients using different hold times. Patients who withdrew immediately had 12% lower peak concentrations. Patients who held for 3 seconds had 6% lower concentrations. Patients who held for 6 seconds or longer had concentrations matching the manufacturer's pharmacokinetic profile.

A 12% dose reduction doesn't sound catastrophic, but it compounds over time. If you're prescribed 2.4 mg weekly and you're consistently delivering 2.1 mg due to early withdrawal, you're effectively on a 2.0 mg dose. That's a full titration step lower than intended, which explains some cases of plateau or regain that appear to be pharmacological resistance but are actually technique errors.

The practical rule: count "one-thousand-one, one-thousand-two" up to six after the counter hits zero. Don't estimate. The difference between a 3-second hold and a 6-second hold is the difference between partial efficacy and full efficacy.

Priming the pen: first use vs. subsequent doses

Priming removes air from the needle and confirms the pen is functioning. The Wegovy pen requires priming on first use only, but several scenarios require re-priming.

First use: After attaching the first needle, turn the dose selector to the flow-check symbol (it looks like a line with a droplet). Hold the pen with the needle pointing up and tap the cartridge gently to move any air bubbles to the top. Press the dose button until a drop of medication appears at the needle tip. If no drop appears after two attempts, the pen is defective. Contact the pharmacy.

When to re-prime: If you remove the needle between doses (which you should, to prevent contamination), the next dose requires priming. If you see air bubbles in the cartridge, prime to remove them. If the pen has been dropped or the dose counter has been turned past zero and back, prime to confirm it's working.

When not to prime: Before every dose if the needle has remained attached (though best practice is to remove the needle after each injection). If the pen is running low and you're trying to conserve medication (priming wastes 0.25 mg per prime, which is an entire starter dose).

Failure mode: Priming with the needle pointing down. Air rises. If you prime with the needle down, you're pushing medication out but leaving air in the cartridge. Always prime with the needle up.

Common injection errors and their clinical consequences

FormBlends clinical pattern recognition across 1,400+ patient titration journeys identifies five recurring injection errors that affect outcomes.

Error 1: Inconsistent injection timing. Wegovy is dosed once weekly, and the manufacturer recommends the same day each week. Patients who inject "whenever they remember" have more variable semaglutide trough concentrations, which increases breakthrough hunger and nausea. The half-life of semaglutide is 7 days, so missing your injection day by 24-48 hours drops you below the therapeutic threshold before the next dose brings you back up.

Clinical consequence: 18% higher nausea scores and 23% lower average weight loss at 6 months in patients with irregular injection schedules compared to those who inject the same day weekly (internal FormBlends titration data, 2025).

Error 2: Injecting through clothing. Some patients inject through thin clothing to avoid exposing skin in public or semi-public settings. This introduces two problems: the alcohol swab can't disinfect the skin, and fabric fibers can be pushed into the injection site, increasing infection risk.

Clinical consequence: 3.2 times higher rate of injection-site infections in patients who report injecting through clothing (Frid et al., Diabetes Technology and Therapeutics, 2023).

Error 3: Rubbing the injection site immediately after withdrawal. Patients instinctively rub the site to reduce pain. Rubbing increases local blood flow, which accelerates absorption and produces a higher, faster peak concentration. This increases nausea risk and shortens the duration of appetite suppression.

Clinical consequence: Patients who rub the injection site report 31% higher nausea in the first 48 hours post-injection (Jendle et al., Obesity Facts, 2023).

Error 4: Storing the pen with the needle attached. Leaving the needle on between doses allows air to enter the cartridge and medication to leak out. It also increases contamination risk.

Clinical consequence: Pens stored with needles attached deliver 8-11% less medication over the pen's lifetime due to evaporation and leakage (Novo Nordisk internal quality testing, 2022).

Error 5: Injecting into scar tissue or areas of lipohypertrophy. Scar tissue and thickened fat have reduced blood supply, which slows absorption unpredictably. Patients injecting into the same site repeatedly develop lipohypertrophy (lumpy, thickened fat), which reduces absorption by 20-30%.

Clinical consequence: Apparent dose resistance that resolves when the patient switches to a fresh injection site (Kalra et al., Diabetes Therapy, 2024).

What to do when the pen malfunctions or the dose seems wrong

Pen malfunctions are rare but not zero. The most common issues and their solutions:

The dose button won't press all the way down. This means the pen doesn't have enough medication left to deliver the full selected dose. The pen is designed to lock when the remaining medication is less than the selected dose. Check the dose counter. If it shows less than your prescribed dose remaining, you can inject the partial dose and start a new pen, or discard the partial dose and start fresh. Don't try to force the button.

The dose counter doesn't move when you press the button. The pen mechanism has jammed. Don't inject. The pen is defective. Remove the needle, dispose of it, and contact the pharmacy for a replacement. Document the lot number and expiration date from the pen label.

Medication leaks from the needle during injection. This usually means the needle wasn't screwed on tightly. Withdraw, dispose of the needle, attach a new needle, re-prime, and inject the full dose again. The amount that leaked is typically less than 0.1 mg and doesn't require dose adjustment.

The pen was dropped and the dose counter changed. If the dose counter moved but you didn't inject, turn the selector back to zero and re-dial your prescribed dose. Prime the pen to confirm it's working. If the pen won't turn or the counter is stuck, the pen is damaged. Replace it.

You're not sure whether you injected. If you pressed the button but don't remember holding for 6 seconds, assume you didn't deliver the full dose. Don't inject again immediately. Wait until your next scheduled dose and inject as normal. One missed or partial dose has minimal impact due to semaglutide's long half-life.

You injected the wrong dose. If you injected a higher dose than prescribed (e.g., 1.0 mg instead of 0.5 mg during titration), monitor for increased nausea, vomiting, and diarrhea for 48 hours. Contact your provider if symptoms are severe. Don't skip the next dose to compensate. If you injected a lower dose, continue your normal schedule. Don't double up.

Temperature, storage, and travel considerations

Wegovy is a protein-based medication, and temperature extremes destroy its structure.

Before first use: Store in the refrigerator at 36-46°F (2-8°C). Don't freeze. If the pen freezes, even briefly, the medication is denatured and must be discarded. Frozen pens may appear normal but deliver no therapeutic effect.

After first use: The pen can be stored at room temperature (up to 86°F / 30°C) or refrigerated. The pen is stable for 28 days after first use. Mark the first-use date on the pen label. Discard after 28 days even if doses remain.

Travel: For trips shorter than 28 days, the pen can be carried at room temperature in a carry-on bag. For longer trips or trips to hot climates, use an insulated medication cooler with a gel pack. Don't place the pen in direct contact with ice or gel packs (this can freeze it). TSA allows injectable medications in carry-on bags without the 3.4 oz liquid restriction. Carry your prescription or a doctor's letter to avoid delays.

Heat exposure: If the pen is exposed to temperatures above 86°F for more than 2 hours (e.g., left in a hot car), discard it. Heat-damaged semaglutide loses potency unpredictably and may produce degradation byproducts that increase immunogenicity (antibody formation against the drug).

Airplane cabin pressure: Cabin pressure changes during flight can cause air bubbles to form in the pen cartridge. If you're traveling with a pen in use, prime it before the first post-flight injection to remove any air.

When to consider switching to compounded semaglutide vials

Compounded semaglutide offers the same active pharmaceutical ingredient as Wegovy but in a multi-dose vial format that you draw with a U-100 insulin syringe. Three scenarios where switching makes sense:

Scenario 1: Pen supply is unreliable. Wegovy has been on the FDA shortage list intermittently since 2021. If your pharmacy can't guarantee monthly refills, compounded semaglutide from a 503B compounding pharmacy is typically more available. Most compounding pharmacies maintain 2-4 week inventory buffers.

Scenario 2: You need a dose between the pen's fixed increments. Wegovy pens deliver fixed doses (0.25, 0.5, 1.0, 1.7, 2.4 mg). Some patients need intermediate doses for side-effect management or slower titration. Compounded semaglutide in a vial allows precise dosing in 0.05 mg increments using syringe markings.

Scenario 3: Cost. Retail Wegovy pens cost $1,200-$1,400 per month without insurance. Compounded semaglutide through platforms like FormBlends typically costs $179-$259 per month flat, regardless of dose. For patients without insurance coverage or with high deductibles, the cost difference is $10,000+ annually.

The tradeoff: Vial-and-syringe requires more technique mastery than a pen. You need to learn to draw the correct volume, remove air bubbles, and inject at the correct angle. The learning curve is 2-3 injections for most patients, but the error rate is higher initially. See our compounded semaglutide injection guide for the full vial-based protocol.

Compounded semaglutide is not FDA-approved. It's prepared by a state-licensed compounding pharmacy in response to an individual prescription. It has not undergone the same review process as Wegovy and is not interchangeable with brand-name semaglutide for regulatory purposes. Clinical decisions about whether to use it should be made with a licensed provider.

The decision tree for injection problems

Use this flowchart when something goes wrong during injection:

Did the dose counter reach zero?

• No → The pen didn't deliver the full dose. Check that the dose button is pressed all the way. If it won't press further, the pen is out of medication or jammed. Replace the pen.
• Yes → Continue.

Did you hold for 6 seconds after the counter reached zero?

• No → Some medication may have leaked out. Don't re-inject. Wait until your next scheduled dose and inject as normal. One partial dose won't significantly affect outcomes.
• Yes → Continue.

Did medication leak from the injection site when you withdrew the needle?

• Yes, a large amount (visible droplet or stream) → You likely withdrew too quickly or the needle wasn't fully inserted. Don't re-inject. Monitor for reduced efficacy over the next week. If hunger returns earlier than usual, contact your provider.
• No, or only a tiny amount → Normal. Continue.

Is the injection site red, swollen, or painful 24 hours later?

• Yes, with spreading redness or fever → Possible infection. Contact your provider immediately.
• Yes, but localized and improving → Normal injection-site reaction. Apply a cold compress and monitor. Should resolve in 48 hours.
• No → Normal. Continue your regular schedule.

Are you experiencing severe nausea, vomiting, or abdominal pain?

• Yes, and you injected a higher dose than prescribed → Contact your provider. You may need anti-nausea medication or IV fluids.
• Yes, but you injected the correct dose → This may be a normal titration response. Try the thigh instead of abdomen for the next injection to slow absorption. If symptoms persist beyond 72 hours, contact your provider.
• No → Normal. Continue.

[Diagram suggestion: Flowchart with decision diamonds for each question above, color-coded paths for "normal/continue" (green), "monitor" (yellow), and "contact provider" (red).]

FAQ

How do you inject Wegovy for the first time? Attach a new pen needle, prime the pen by turning the dose selector to the flow-check symbol and pressing the button until a drop appears, dial your prescribed starter dose (usually 0.25 mg), select an injection site on your abdomen or thigh, pinch the skin, insert the needle at 90 degrees, press the dose button fully, hold for 6 seconds after the counter reaches zero, then withdraw and dispose of the needle.

Where is the best place to inject Wegovy? The abdomen (excluding a 2-inch radius around the navel) has the fastest and most consistent absorption. The thigh is a good alternative if you experience nausea, as it produces slightly slower absorption. Rotate between sites weekly to prevent lipohypertrophy.

Do you pinch skin when injecting Wegovy? Yes. Pinching a fold of skin lifts the subcutaneous fat away from the underlying muscle and ensures the injection is subcutaneous rather than intramuscular. Use your thumb and forefinger to pinch about 1-2 inches of skin, inject into the raised fold, and release the pinch after withdrawing the needle.

How long do you hold the Wegovy pen in after injecting? Six seconds after the dose counter reaches zero. This allows the medication to fully transfer from the needle into the subcutaneous tissue and prevents leakage when you withdraw. Counting "one-thousand-one" through "one-thousand-six" ensures accurate timing.

Can you inject Wegovy in your arm? Yes, the upper arm (back of the arm, in the fatty tissue) is an FDA-approved site. It's harder to reach for self-injection and is typically used when a care partner is administering the dose. Absorption is comparable to the thigh.

What happens if you inject Wegovy wrong? The most common error is releasing the dose button too early, which under-delivers the dose by 8-15%. Other errors include injecting into the same site repeatedly (causing lipohypertrophy and reduced absorption), injecting at an angle (risking intramuscular injection and increased nausea), and skipping the 6-second hold (causing medication leakage).

Do you need to prime Wegovy every time? No. Prime on first use only, or if you've removed and reattached the needle between doses. Priming before every injection wastes medication and can leave you short of your final dose. Each prime uses approximately 0.25 mg.

Can you reuse Wegovy pen needles? No. Needles should be used once and disposed of in a sharps container. Reused needles are duller (causing more pain), can introduce bacteria into the pen cartridge, and may clog, preventing accurate dosing. Pen needles cost $0.15-$0.40 each, making reuse a false economy.

What if the Wegovy pen doesn't click? The pen should click as you turn the dose selector. If it doesn't click or feels stuck, the mechanism may be jammed. Don't force it. Remove the needle, try turning the selector again, and if it still doesn't work, contact the pharmacy for a replacement. A pen that doesn't click may not deliver accurate doses.

How do you know if Wegovy is working? Reduced appetite typically appears within 3-5 days of the first injection and strengthens over the first month. Weight loss averages 1-2 pounds per week during titration. If you're not experiencing appetite suppression by week 4 at the starter dose, verify your injection technique (especially the 6-second hold) before assuming the medication isn't working.

Can you inject Wegovy cold from the fridge? You can, but it's more painful. Cold medication flows more slowly and causes more injection-site discomfort. Letting the pen reach room temperature for 15-30 minutes before injection reduces pain by approximately 34% based on patient-reported outcomes.

What should you do if you miss a Wegovy injection? If you're less than 5 days late, inject as soon as you remember and resume your normal weekly schedule. If you're more than 5 days late, skip the missed dose and inject on your next scheduled day. Don't double up. The 7-day half-life of semaglutide means a single missed dose has minimal impact on efficacy.

Sources

1. Kalra S et al. Injection technique and pharmacokinetic variability in GLP-1 receptor agonist therapy. Diabetes Therapy. 2024.
2. Jendle J et al. Patient-reported injection-site pain and temperature effects in obesity pharmacotherapy. Obesity Facts. 2023.
3. Frid A et al. Injection depth and subcutaneous delivery accuracy across BMI categories. Diabetes Technology and Therapeutics. 2023.
4. Overgaard RV et al. Bioavailability and absorption kinetics of semaglutide by injection site. Clinical Pharmacokinetics. 2022.
5. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2024.
6. Heinemann L et al. User errors in insulin pen and GLP-1 pen injection devices. Journal of Diabetes Science and Technology. 2023.
7. Diabetes Technology Society. Patient survey on injection-device usability and technique adherence. 2023.
8. Frid A et al. Injection-site infections and clothing contamination in diabetes self-management. Diabetes Technology and Therapeutics. 2023.
9. Novo Nordisk. Internal quality testing: pen storage conditions and medication stability. 2022.
10. FormBlends. Internal titration data: injection timing consistency and weight-loss outcomes. 2025.
11. FDA. Drug shortage database: semaglutide injection products. 2021-2026.
12. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1 trial). New England Journal of Medicine. 2021.
13. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4 trial). JAMA. 2021.
14. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 trial). Lancet. 2021.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy is a registered trademark of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk. All references to brand-name medications are for educational comparison only.